NEW YORK (GenomeWeb News) – The Ontario Institute for Cancer Research has pumped C$52 million ($49.3 million) into several genomic and translational research programs aimed at developing new diagnostics and treatments for cancer, OICR said today.

The new investment will concentrate on supporting programs and research areas that the institute deems to be of high interest, including ones centering on cancer genomics and stem cells, drug discovery, informatics, and pathology.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

An Australian study of personalized medicine has run into problems as it recruits patients.

In Science this week: mtDNA analysis give glimpse into decline of Neanderthals in Europe, and more.

The University of Arizona's Raina Maier writes that an understanding of the Earth's microbiome is needed.

The proposed Canadian budget emphasizes partnerships with industry, Nature News reports.

Apr
29
Sponsored by
Covance

This online seminar will review case studies demonstrating the clinical utility of CTCs and cfDNA to define and characterize a variety of dynamic genomic changes throughout the course of cancer detection and treatment.